Clinical Trial

Maternal Choline Supplementation and Offspring Cognition in Adolescence

Study acronym: CholTeens
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated August 22, 2024 (before its estimated October 2024 completion). Its status may not reflect the trial's current state.
Summary
The goal of this 13-year follow up of a randomized control trial is to study the effect of maternal choline supplementation on offspring cognition in adolescence. The main question\[s\] it aims to answer are: Does a higher dose of maternal choline choline (930 mg/d day supplementation) lead to improved cognition in adolescence including hippocampal-dependent episodic memory and executive functioning when compared to lower dose supplementation (480 mg/d). In this follow-up of a clinical trial participants will complete online cognition testing and emotion testing.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-05-12; most recent amendment 2024-08-21.
Status change: Not Yet Recruiting → Enrolling by Invitation 2024-02-08
Trial Details
NCT Number NCT05859126
Lead Sponsor Cornell University
Conditions Cognitive Deficit in Attention, Executive Dysfunction, Emotional Regulation
Enrollment 26 participants
Start Date 2023-06-23
Primary Completion 2024-10 (estimated)
Study Completion 2024-12 (estimated)
Updated on ClinicalTrials.gov 2024-08-22